| 000 | 01260cam a22003734a 4500 | ||
|---|---|---|---|
| 001 | 15879823 | ||
| 003 | BD-DhUL | ||
| 005 | 20220405123459.0 | ||
| 008 | 090821s2010 nyua b 001 0 eng | ||
| 010 | _a 2009034997 | ||
| 016 | 7 |
_a101513683 _2DNLM |
|
| 020 | _a9781138036178 (hbk) | ||
| 035 | _a(OCoLC)ocn434319189 | ||
| 040 |
_aDNLM/DLC _cDLC _dYDX _dBTCTA _dYDXCP _dNLM _dIXA _dDLC _dBD-DhUL |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRM301.25 _b.A28 2010 |
| 060 | 0 | 0 |
_aW1 _bDR893B v.205 2010 |
| 060 | 1 | 0 |
_aQV 736 _bA188 2010 |
| 082 |
_a615.19 _bACT |
||
| 245 | 0 | 0 |
_aActive pharmaceutical ingredients : _bdevelopment, manufacturing, and regulation / _cedited by Stanley H. Nusim. |
| 250 | _a2nd ed. | ||
| 260 |
_aNew York : _bInforma Healthcare, _c2010 (2022 printing). |
||
| 300 |
_axv, 433 p. : _bill. ; _c24 cm. |
||
| 365 |
_aIRS _b3495.00 |
||
| 490 | 0 |
_aDrugs and the pharmaceutical sciences ; _v205. |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 | _aDrug development. | |
| 650 | 0 | _aPharmaceutical technology. | |
| 650 | 0 |
_aDrugs _xLaw and legislation. |
|
| 650 | 0 | _aPharmaceutical industry. | |
| 700 | 1 |
_aNusim, Stanley H. _eed. |
|
| 830 | 0 |
_aDrugs and the pharmaceutical sciences ; _vv. 205. |
|
| 942 |
_2ddc _cBK |
||
| 999 |
_c255622 _d255622 |
||